Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599274 · ClinicalTrials.gov registry record
Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 136
- Enrollment target
NCT00599274 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 136 participants.
The verdict
NCT00599274 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if weekly Avonex works as well as three times a week Rebif in subjects with relapsing multiple sclerosis.
Interventions
- DRUG Interferon beta-1a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2002-08 |
| Est. Completion | 2003-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599274
The ClinicalTrials.gov registry entry for NCT00599274 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interferon beta-1a is the first listed.
NCT00599274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00599274 about?
NCT00599274 is a clinical study titled "Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis". The purpose of this study is to find out if weekly Avonex works as well as three times a week Rebif in subjects with relapsing multiple sclerosis.
What is the current status of trial NCT00599274?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2002-08. Estimated completion is 2003-05.
What interventions are being tested in trial NCT00599274?
The interventions under investigation include: Interferon beta-1a (DRUG).
Who is sponsoring clinical trial NCT00599274?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.